Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET Corporate Highlights Third quarter of 2023 GAAP net income.
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) has announced that chief financial officer Hans-Peter Rudolf is stepping down from his position to pursue.
By Joe Hoppe Shield Therapeutics said Chief Financial Officer Hans-Peter Rudolf will step down from the role on Oct. 20 to pursue other opportunities, and.
Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next week Friday.